Advertisement

Prognostic Value of Uric Acid in Patients With ST-Elevated Myocardial Infarction Undergoing Primary Coronary Intervention

Published:November 21, 2011DOI:https://doi.org/10.1016/j.amjcard.2011.09.042
      Elevated uric acid (UA) levels have been associated with cardiovascular disease in epidemiologic studies. The relation between UA levels and long-term outcomes in patients with ST-segment elevation myocardial infarction who undergo primary percutaneous coronary intervention is not known. Data from 2,249 consecutive patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention were evaluated. Patients were divided into 2 groups with high or low UA using upper limits of normal of 6 mg/dl for women and 7 mg/dl for men. There were 1,643 patients in the low-UA group (mean age 55.9 ± 11.6 years, 85% men) and 606 patients in the high-UA group (mean age 60.5 ± 12.6 years, 76% men). Serum UA levels were 8.0 ± 1.5 mg/dl in the high-UA group and 5.2 ± 1.0 mg/dl in the low-UA group (p <0.001). The in-hospital mortality rate was significantly higher in patients with high UA levels (9% vs 2%, p <0.001), as was the rate of adverse outcomes in patients with high UA. The mean follow-up time was 24.3 months. Cardiovascular mortality, reinfarction, target vessel revascularization, heart failure, and major adverse cardiac events were all significantly higher in the high-UA group. In a multivariate analyses, high plasma UA levels were an independent predictor of major adverse cardiac events in the hospital (odds ratio 2.03, 95% confidence interval 1.25 to 3.75, p = 0.006) and during long-term follow-up (odds ratio 1.64, 95% confidence interval 1.05 to 2.56, p = 0.03). In conclusion, high UA levels on admission are independently associated with in-hospital and long-term adverse outcomes in patients with ST-segment elevation myocardial infarction who undergo primary percutaneous coronary intervention.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bickel C.
        • Rupprecht H.J.
        • Blankenberg S.
        • Rippin G.
        • Hafner G.
        • Daunhauer A.
        • Hofmann K.P.
        • Meyer J.
        Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease.
        Am J Cardiol. 2002; 89: 12-17
        • Bos M.J.
        • Koudstaal P.J.
        • Hofman A.
        • Witteman J.C.
        • Breteler M.M.
        Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study.
        Stroke. 2006; 37: 1503-1507
        • Niskanen L.K.
        • Laaksonen D.E.
        • Nyyssönen K.
        • Alfthan G.
        • Lakka H.M.
        • Lakka T.A.
        • Salonen J.T.
        Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study.
        Arch Intern Med. 2004; 164: 1546-1551
        • Freedman D.S.
        • Williamson D.F.
        • Gunter E.W.
        • Byers T.
        Relation of serum uric acid to mortality and ischemic heart disease.
        Am J Epidemiol. 1995; 141: 637-644
        • Culleton B.F.
        • Larson M.G.
        • Kannel W.B.
        • Levy D.
        Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study.
        Ann Intern Med. 1999; 131: 7-13
        • Lazzeri C.
        • Valente S.
        • Chiostri M.
        • Sori A.
        • Bernardo P.
        • Gensini G.F.
        Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience.
        Int J Cardiol. 2010; 138: 206-209
        • Levey A.S.
        • Bosch J.P.
        • Lewis J.B.
        • Greene T.
        • Rogers N.
        • Roth D.
        A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation.
        Ann Intern Med. 1999; 130: 461-470
        • Schiller N.B.
        • Shah P.M.
        • Crawford M.
        • DeMaria A.
        • Devereux R.
        • Feigenbaum H.
        • Gutgesell H.
        • Reichek N.
        • Sahn D.
        • Schnittger I.
        • American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms
        Recommendations for quantitation of the left ventricle by two-dimensional echocardiography.
        J Am Soc Echocardiogr. 1989; 2: 358-367
        • Chesebro J.H.
        • Knatterud G.
        • Roberts R.
        • Borer J.
        • Cohen L.S.
        • Dalen J.
        • Dodge H.T.
        • Francis C.K.
        • Hillis D.
        • Ludbrook P.
        Thrombolysis In Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase.
        Circulation. 1987; 76: 142-154
        • Killip T.
        • Kimball J.T.
        Treatment of myocardial infarction in a coronary care unit.
        Am J Cardiol. 1967; 20: 457-464
        • Kojima S.
        • Sakamoto T.
        • Ishihara M.
        • Kimura K.
        • Miyazaki S.
        • Yamagishi M.
        • Tei C.
        • Hiraoka H.
        • Sonoda M.
        • Tsuchihashi K.
        • Shimoyama N.
        • Honda T.
        • Ogata Y.
        • Matsui K.
        • Ogawa H.
        • Japanese Acute Coronary Syndrome Study (JACSS) Investigators
        Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study).
        Am J Cardiol. 2005; 96: 489-495
      1. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF. Uric acid in the early risk stratification of ST-elevation myocardial infarction. Intern Emerg Med. In press.

        • Akpek M.
        • Kaya M.G.
        • Uyarel H.
        • Yarlioglues M.
        • Kalay N.
        • Gunebakmaz O.
        • Dogdu O.
        • Ardic I.
        • Elcik D.
        • Sahin O.
        • Oguzhan O.
        • Ergin A.
        • Gibson C.M.
        The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI.
        Atherosclerosis. 2011; 219: 334-341
        • Damman P.
        • Beijk M.A.
        • Kuijt W.J.
        • Verouden N.J.
        • van Geloven N.
        • Henriques J.P.
        • Baan J.
        • Vis M.M.
        • Meuwissen M.
        • van Straalen J.P.
        • Fischer J.
        • Koch K.T.
        • Piek J.J.
        • Tijssen J.G.
        • de Winter R.J.
        Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
        J Am Coll Cardiol. 2011; 57: 29-36
        • Schoos M.M.
        • Kelbæk H.
        • Kofoed K.F.
        • Køber L.
        • Kløvgaard L.
        • Helqvist S.
        • Engstrøm T.
        • Saunamäki K.
        • Jørgensen E.
        • Holmvang L.
        • Clemmensen P.
        Usefulness of preprocedure high-sensitivity C-reactive protein to predict death, recurrent myocardial infarction, and stent thrombosis according to stent type in patients with ST-segment elevation myocardial infarction randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention.
        Am J Cardiol. 2011; 107: 1597-1603
        • Huczek Z.
        • Kochman J.
        • Filipiak K.J.
        • Horszczaruk G.J.
        • Grabowski M.
        • Piatkowski R.
        • Wilczynska J.
        • Zielinski A.
        • Meier B.
        • Opolski G.
        Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention.
        J Am Coll Cardiol. 2005; 46: 284-290
        • Kaya M.G.
        • Ozdogru I.
        • Kalay N.
        • Dogan A.
        • Inanc T.
        • Gul I.
        • Gunebakmaz O.
        • Oguzhan A.
        Plasma B-type natriuretic peptide in diagnosing inferior myocardial infarction with right ventricular involvement.
        Coron Artery Dis. 2008; 19: 609-613
        • Uyarel H.
        • Ergelen M.
        • Cicek G.
        • Kaya M.G.
        • Ayhan E.
        • Turkkan C.
        • Yildirim E.
        • Kirbas V.
        • Onturk E.T.
        • Erer H.B.
        • Yesilcimen K.
        • Gibson C.M.
        Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction.
        Coron Artery Dis. 2011; 22: 138-144
        • Naghavi M.
        • Libby P.
        • Falk E.
        • Casscells S.W.
        • Litovsky S.
        • Rumberger J.
        • Badimon J.J.
        • Stefanadis C.
        • Moreno P.
        • Pasterkamp G.
        • Fayad Z.
        • Stone P.H.
        • Waxman S.
        • Raggi P.
        • Madjid M.
        • Zarrabi A.
        • Burke A.
        • Yuan C.
        • Fitzgerald P.J.
        • Siscovick D.S.
        • de Korte C.L.
        • Aikawa M.
        • Juhani Airaksinen K.E.
        • Assmann G.
        • Becker C.R.
        • Chesebro J.H.
        • Farb A.
        • Galis Z.S.
        • Jackson C.
        • Jang I.K.
        • Koenig W.
        • Lodder R.A.
        • March K.
        • Demirovic J.
        • Navab M.
        • Priori S.G.
        • Rekhter M.D.
        • Bahr R.
        • Grundy S.M.
        • Mehran R.
        • Colombo A.
        • Boerwinkle E.
        • Ballantyne C.
        • Insull Jr, W.
        • Schwartz R.S.
        • Vogel R.
        • Serruys P.W.
        • Hansson G.K.
        • Faxon D.P.
        • Kaul S.
        • Drexler H.
        • Greenland P.
        • Muller J.E.
        • Virmani R.
        • Ridker P.M.
        • Zipes D.P.
        • Shah P.K.
        • Willerson J.T.
        From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I.
        Circulation. 2003; 108: 1664-1672
        • Ruggiero C.
        • Cherubini A.
        • Ble A.
        • Bos A.J.
        • Maggio M.
        • Dixit V.D.
        • Lauretani F.
        • Bandinelli S.
        • Senin U.
        • Ferrucci L.
        Uric acid and inflammatory markers.
        Eur Heart J. 2006; 27: 1174-1181
        • Many A.
        • Hubel C.A.
        • Roberts J.M.
        Hyperuricemia and xanthine oxidase in preeclampsia, revisited.
        Am J Obstet Gynecol. 1996; 174: 288-291
        • Kato M.
        • Hisatome I.
        • Tomikura Y.
        • Kotani K.
        • Kinugawa T.
        • Ogino K.
        • Ishida K.
        • Igawa O.
        • Shigemasa C.
        • Somers V.K.
        Status of endothelial dependent vasodilation in patients with hyperuricemia.
        Am J Cardiol. 2005; 96: 1576-1578
        • Erdogan D.
        • Gullu H.
        • Caliskan M.
        • Yildirim E.
        • Bilgi M.
        • Ulus T.
        • Sezgin N.
        • Muderrisoglu H.
        Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults.
        Int J Clin Pract. 2005; 59: 1276-1282
        • Caymaz O.
        Chronic heart failure and uric acid.
        Türk J Cardiol. 2006; 9: 110-114
        • Saugstad O.D.
        Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury.
        Pediatrics. 1996; 98: 103-107
        • Romano M.
        • Buffoli F.
        • Tomasi L.
        • Aroldi M.
        • Lettieri C.
        • Ferrari M.R.
        • Zanini R.
        The no-reflow phenomenon in acute myocardial infarction after primary angioplasty: incidence, predictive factors, and long-term outcomes.
        J Cardiovasc Med. 2008; 9: 59-63
        • Pohl U.
        • Busse R.
        Endothelium-dependent modulation of vascular tone and platelet function.
        Eur Heart J. 1990; 11: 35-42
        • Parent R.
        • Paré R.
        • Lavallée M.
        Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs.
        Am J Physiol. 1992; 262: 10-16
        • Farquharson C.A.
        • Butler R.
        • Hill A.
        • Belch J.J.
        • Struthers A.D.
        Allopurinol improves endothelial dysfunction in chronic heart failure.
        Circulation. 2002; 106: 221-226
        • Kaya M.G.
        • Arslan F.
        • Abaci A.
        • van der Heijden G.
        • Timurkaynak T.
        • Cengel A.
        Myocardial blush grade: a predictor for major adverse cardiac events after primary PTCA with stent implantation for acute myocardial infarction.
        Acta Cardiol. 2007; 62: 445-451